Picture of Dong-A ST Co logo

170900 Dong-A ST Co Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m-6.64%
3m-7.82%
6m+10.09%
1yr+15.87%
Volume Change (%)
10d/3m-44.48%
Price vs... (%)
52w High-26.14%
50d MA-10.37%
200d MA+1.93%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)18.74
PEG Ratio (f)0.48
EPS Growth (f)64.26%
Dividend Yield (f)1.12%
Valuation (ttm)IndustryMarket
Price to Book Value0.85
Price to Tang. Book1.05
Price to Free Cashflown/a
Price to Sales0.85
EV to EBITDA21.73

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital0.86%
Return on Equity1.67%
Operating Margin1.13%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueKR₩m612,310.6586,728.13593,227.92635,392.68663,980.37666,825702,7853.19%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+482.61-48.69-40.84-40.77+35.92+124.44+12.78n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Dong-A ST Co EPS forecast chart

Profile Summary

Dong-A ST Co Ltd is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. It produces and sells diagnostic reagents for hepatitis E, I, A and B. In addition, it is engaged in the production and sale of medical devices including implants for artificial joint and maxillofacial surgery. The Company distributes its products in domestic and overseas markets such as Brazil, Turkey and Cambodia.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
March 4th, 2013
Public Since
April 8th, 2013
No. of Shareholders
15,910
No. of Employees
1,591
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
kr flag iconKorea Exchange - KSE
Shares in Issue
8,646,322.62

170900 Share Price Performance

Upcoming Events for 170900

Q2 2024 Dong-A ST Co Ltd Earnings Release

Q3 2024 Dong-A ST Co Ltd Earnings Release

Similar to 170900

Picture of Aprogen Biologics logo

Aprogen Biologics

kr flag iconKorea Exchange - KSE

Picture of Boryung logo

Boryung

kr flag iconKorea Exchange - KSE

Picture of Bukwang Pharm Co logo

Bukwang Pharm Co

kr flag iconKorea Exchange - KSE

Picture of Chong Kun Dang Pharmaceutical logo

Chong Kun Dang Pharmaceutical

kr flag iconKorea Exchange - KSE

Picture of CKD Bio logo

CKD Bio

kr flag iconKorea Exchange - KSE

FAQ